Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Dutasteride-containing mesotherapy effectively treats female hair loss, improving density and thickness with minimal side effects.

Finasteride 5mg/day improves hair loss in normoandrogenic Asian women.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

Finasteride is effective and safe for treating hidradenitis suppurativa in both adults and some younger patients.

Finasteride effectively reduces excess hair in women with certain conditions.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Finasteride reduces Hidradenitis Suppurativa flare-ups in children and teens, but long-term safety is unknown.

MK-386 lowers DHT in blood and skin but not in semen.

Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.

Fludalanine failed as an effective oral antibiotic despite efforts.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Bicalutamide added no extra benefit over minoxidil alone for female-pattern hair loss.

A hair growth ointment improved hair length in a family with a genetic hair growth condition.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Blocking androgens at birth reduces sexual motivation in male rats.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Finasteride may worsen blood sugar control in diabetic patients.

Treatment during development affects hormone balance and sexual behavior in male rats.

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.